NCT06165068View on ClinicalTrials.gov

Effects of Antiplatelet and Antioxidant Agents on Drusen Progression: A Pilot, Prospective Cohort Study

PHASE3RecruitingINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

December 31, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

September 30, 2026

Conditions
Dry Age-related Macular Degeneration
Interventions
DRUG

Aspirin 81Mg Ec Tab

Patients take aspirin 81 mg per day.

DRUG

Clopidogrel

Patients take clopidogrel 75 mg per day.

DRUG

N-acetylcysteine

Patients are given N-acetylcysteine 600 mg per day.

Trial Locations (1)

10300

RECRUITING

Department of ophthalmology, Faculty of medicine, Vajira hospital, Navamindradhiraj University, Bangkok

All Listed Sponsors
lead

Navamindradhiraj University

OTHER